Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 71610-926 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 71610 0926 30

Label - 71610 0926 30

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

Not available.*

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

This appears to be a medication dosage chart displaying the percentage of patients who improved with Pregabalin at 100mg and 80mg three times a day compared to a placebo. The chart also shows the percentage of improvement in pain from the baseline.*

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Figure 8 - pregabalin 09

Figure 8 - pregabalin 09

This is a data set consisting of responder rates for different treatments. The responder rates are listed as percentages for the treatments "Placebo," "2.5 mg/kg/day," and "10 mg/kg/day." The values range from 22.6% to 40.6%.*

Figure 9 - pregabalin 10

Figure 9 - pregabalin 10

This is a chart showing the percentage of patients who experienced improvement in pain after taking different doses of a medication named Preguissin. It indicates that 100% of patients showed improvement after taking a 4807 car dose of Pregoain, while the percentage of improvement is not specified for the other doses mentioned. The document also includes information on the percent improvement in pain from the baseline.*

Figure 10 - pregabalin 11

Figure 10 - pregabalin 11

Figure 11 - pregabalin 12

Figure 11 - pregabalin 12

The text provides information on the percentage of subjects showing improvement over time, specifically from baseline to week 12. It mentions the usage of Pregabalin in this context. The data points mentioned include percentages like 20, 90, and 100.*

Figure 12 - pregabalin 13

Figure 12 - pregabalin 13

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.